·2,447,543篇论文数据，部分数据来源于NoteExpress
Peto got permission to unblind data from two ongoing studies involving 20, 000 patients: SHARP, testing Vytorin vs. placebo and Zocor in kidney patients, and IMPROVE-IT, which compares Vytorin and Zocor in patients at risk for heart attacks.
FORBES: Magazine Article
应用推荐
模块上移
模块下移
不移动